Daniel Ting/LinkedIn
Oct 9, 2025, 06:55
All You Need to Know About Generative AI in Medicine from Daniel Ting and Colleagues
Joao Monteiro, Chief Editor at Nature Medicine, shared on LinkedIn:
”All you need to know about generative AI in medicine in a single Review!
Daniel Ting and colleagues survey what has happened (and what has not) in medicine since the release of ChatGPT and the large-language models boom.
- Technical evolution of generative artificial intelligence
- Clinical applications of generative artificial intelligence
- Evaluation and quality assurance
- Future opportunities”
Read the full article in Nature Medicine.
Article: Generative artificial intelligence in medicine
Authors: Zhen Ling Teo, Arun James Thirunavukarasu, Kabilan Elangovan, Haoran Cheng, Prasanth Moova, Brian Soetikno, Christopher Nielsen, Andreas Pollreisz, Darren Shu Jeng Ting, Robert J. T. Morris, Nigam H. Shah, Curtis P. Langlotz, Daniel Ting

Stay updated on all scientific advances with Hemostasis Today.
Andreas Pollreisz
Arun James Thirunavukarasu
Brian Soetikno
Christopher Nielsen
Curtis P. Langlotz
Daniel Ting
Darren Shu Jeng Ting
Generative AI
Haoran Cheng
Health
Hematology
Hemostasis
Hemostasis Today
Kabilan Elangovan
Medicine
Nature Medicine
Nigam H. Shah
Prasanth Moova
Robert J. T. Morris
thrombosis
Zhen Ling Teo
-
Nov 27, 2025, 16:00Nathan Connell on WFH AI Summaries from the Global Forum
-
Nov 27, 2025, 15:49Piotr Czempik: Rethinking Coagulation in Acute Liver Dysfunction
-
Nov 27, 2025, 15:35Overwhelmed? A Leader’s Guide from Mark Crowther to Getting Back on Track
-
Nov 27, 2025, 15:10Wolfgang Miesbach’s Top 10 Picks for TTP and Thrombosis from ASH 2025
-
Nov 27, 2025, 14:24ICCBBA’s Executive Director Eoin McGrath Chairs a Dynamic Session on AI, Innovation and Informatics in Transfusion Medicine
-
Nov 27, 2025, 13:26Wolfgang Miesbach’s Top 10 Picks for Bleeding Disorders from ASH 2025
-
Nov 27, 2025, 11:19Priya Prasad Presents a Case of Severe Hypotensive Transfusion Reaction
-
Nov 27, 2025, 04:07Eugene Tang Presents Highlights from UK Stroke Forum 2025
-
Nov 27, 2025, 03:47Michael Makris: I Believe the Time Has Come to Consider Emicizumab Up Front in Persons with Acquired Hemophilia
